Fiji Declares National HIV Emergency as Prevalence Hits One in 60 Adults

The declaration follows Ministry of Health surveillance showing new diagnoses rising from 129 in 2022 to over 400 in 2025, concentrated among people who inject drugs in urban centers. Seroprevalence surveys conducted with UNAIDS support estimated adult prevalence at 1.67 percent, far above prior regional baselines. Contact tracing data indicate a shift from heterosexual transmission to shared needles, with 62 percent of recent cases reporting recent injection drug use.

Comparable Pacific outbreaks remain rare; only Papua New Guinea has recorded sustained high incidence, yet Fiji’s compact geography and limited harm-reduction infrastructure amplify spread risk. Observational data from needle-exchange pilots in Suva show 40 percent lower incident infection among participants versus non-participants, though sample sizes stay small and loss to follow-up exceeds 25 percent. Funding shortfalls and stigma around drug use have delayed scale-up, patterns seen in earlier Eastern European epidemics.

Next steps hinge on whether the government secures external financing for widespread needle and syringe programs plus opioid agonist therapy by mid-2027. Without randomized evaluations of coverage thresholds, it will remain unclear whether incidence can be driven below 2 per 1,000 person-years. An independent audit of surveillance methods is also required to confirm prevalence estimates.